Separately in this cohort, high CDK2AP1 and high AR expression were significantly associated with metastatic disease (p value 0.034 and 0.019, respectively) and when combined, there is a higher rate of metastatic disease observed in high CDK2AP1 and high AR expression cases (p value 0.013). Here, CDK2AP1 is linked to metastatic neoplasm.